A.HryhorenkoJ
When in doubt, contact the vendor and ask for the peptide sequence or confirm the molecular weight
For athletes looking to improve exercise performance, a dose of 2-3 grams per day is commonly used
The dose itself might not change dramatically from the systemic protocol (e.g., 250-350mcg total per day), but the location of the administration is the key variable
Also, the influence of selected oxidative stress gene polymorphisms on melanocyte damage is described to understand their involvement in the disease
Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism
